BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Osumi H, Fujisaki J, Suganuma T, Horiuchi Y, Omae M, Yoshio T, Ishiyama A, Tsuchida T, Miki K. A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication. PLoS One. 2017;12:e0183980. [PMID: 28854276 DOI: 10.1371/journal.pone.0183980] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Chapelle N, Osmola M, Martin J, Blin J, Leroy M, Jirka I, Moussata D, Lamarque D, Olivier R, Tougeron D, Hay-lombardie A, Bigot-corbel E, Masson D, Mosnier J, Matysiak-budnik T. Serum Pepsinogens Combined with New Biomarkers Testing Using Chemiluminescent Enzyme Immunoassay for Non-Invasive Diagnosis of Atrophic Gastritis: A Prospective, Multicenter Study. Diagnostics 2022;12:695. [DOI: 10.3390/diagnostics12030695] [Reference Citation Analysis]
2 Gan J, Cheng RG, Wang SF. Diagnostic value of serum pepsinogen in gastric diseases. Shijie Huaren Xiaohua Zazhi 2018; 26(36): 2115-2119 [DOI: 10.11569/wcjd.v26.i36.2115] [Reference Citation Analysis]
3 Di Mario F, Crafa P, Barchi A, Franzoni L, Franceschi M, Russo M, Bricca L, Brozzi L, Rodriguez Castro K, Rugge M. Pepsinogen II in gastritis and Helicobacter pylori infection. Helicobacter 2022;:e12872. [PMID: 34997989 DOI: 10.1111/hel.12872] [Reference Citation Analysis]
4 Furihata C. Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method. Proc Jpn Acad Ser B Phys Biol Sci 2021;97:462-78. [PMID: 34629355 DOI: 10.2183/pjab.97.023] [Reference Citation Analysis]
5 Cho JH, Jeon SR, Jin SY, Park S. Analysis of factors associated with recovery of the serum pepsinogen ratio after Helicobacter pylori eradication: a long-term follow-up study in Korea. Scand J Gastroenterol 2019;54:1306-14. [PMID: 31702966 DOI: 10.1080/00365521.2019.1686058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cho JH, Jin SY. Optimized diagnosis of Helicobacter pylori and tailored eradication therapy for preventing gastric cancer: a proposal for SHAKE strategy. Expert Rev Gastroenterol Hepatol 2020;14:553-64. [PMID: 32410515 DOI: 10.1080/17474124.2020.1770594] [Reference Citation Analysis]
7 Kim YJ, Chung WC. Is serum pepsinogen testing necessary in populationbased screening for gastric cancer? Korean J Intern Med 2020;35:544-6. [PMID: 32392661 DOI: 10.3904/kjim.2020.139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Mattar R, Marques SB, Ribeiro IB, Visconti TAC, Funari M, DE Moura EGH. DIAGNOSTIC ACCURACY OF GASTROPANEL® FOR ATROPHIC GASTRITIS IN BRAZILIAN SUBJECTS AND THE EFFECT OF PROTON PUMP INHIBITORS. Arq Gastroenterol 2020;57:154-60. [PMID: 32609157 DOI: 10.1590/S0004-2803.202000000-29] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Nyssen OP, Pérez-Aisa Á, Tepes B, Rodrigo-Sáez L, Romero PM, Lucendo A, Castro-Fernández M, Phull P, Barrio J, Bujanda L, Ortuño J, Areia M, Brglez Jurecic N, Huguet JM, Alcaide N, Voynovan I, María Botargues Bote J, Modolell I, Pérez Lasala J, Ariño I, Jonaitis L, Dominguez-Cajal M, Buzas G, Lerang F, Perona M, Bordin D, Axon T, Gasbarrini A, Marcos Pinto R, Niv Y, Kupcinskas L, Tonkic A, Leja M, Rokkas T, Boyanova L, Shvets O, Venerito M, Bytzer P, Goldis A, Simsek I, Lamy V, Przytulski K, Kunovský L, Capelle L, Milosavljevic T, Caldas M, Garre A, Mégraud F, O'Morain C, Gisbert JP; Hp-EuReg Investigators. Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg). Helicobacter 2020;25:e12686. [PMID: 32173974 DOI: 10.1111/hel.12686] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Noh G, Kim N, Choi Y, Lee HS, Hwang YJ, Kim HJ, Yoon H, Shin CM, Park YS, Lee DH. Long-term follow up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication. J Gastroenterol Hepatol 2020;35:1540-8. [PMID: 32090375 DOI: 10.1111/jgh.15017] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chen XZ, Huang CZ, Hu WX, Liu Y, Yao XQ. Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening. Chin Med J (Engl). 2018;131:1232-1239. [PMID: 29722342 DOI: 10.4103/0366-6999.231512] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
12 Mansour-Ghanaei F, Joukar F, Baghaee M, Sepehrimanesh M, Hojati A. Only serum pepsinogen I and pepsinogen I/II ratio are specific and sensitive biomarkers for screening of gastric cancer. Biomol Concepts 2019;10:82-90. [PMID: 31188744 DOI: 10.1515/bmc-2019-0010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
13 Quach DT, Hiyama T, Gotoda T. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice. World J Gastroenterol 2019; 25(27): 3546-3562 [PMID: 31367156 DOI: 10.3748/wjg.v25.i27.3546] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
14 Katoh M. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review). Int J Mol Med 2018;42:713-25. [PMID: 29786110 DOI: 10.3892/ijmm.2018.3689] [Cited by in Crossref: 19] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
15 Dutta AK, Phull PS. Treatment of Helicobacter pylori infection in the presence of penicillin allergy. World J Gastroenterol 2021; 27(44): 7661-7668 [PMID: 34908805 DOI: 10.3748/wjg.v27.i44.7661] [Reference Citation Analysis]